Nutex Health (NUTX) FCF Margin (2010 - 2026)

Nutex Health has disclosed FCF Margin across 17 years of filings, most recently posting 34.33% for Q1 2026.

• FCF Margin for Q1 2026 came in at 34.33%, up 1030.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 30.57% (up 1945.0% YoY), and the FY2025 annual result was 28.06%, up 2372.0% from the prior year.
• FCF Margin came in at 34.33% for Q1 2026 at Nutex Health, down from 45.48% in the prior quarter.
• In the past five years, FCF Margin ranged from a high of 45.48% in Q4 2025 to a low of 46.46% in Q3 2022.
• The 5-year median for FCF Margin is 10.86% (2025), against an average of 11.36%.
• Peak annual rise in FCF Margin reached 6246 bps in 2022, while the deepest fall reached 11332 bps in 2022.
• Nutex Health's FCF Margin stood at 23.05% in 2022, then plunged by 106 bps to 1.36% in 2023, then soared by 90 bps to 0.13% in 2024, then surged by 34457 bps to 45.48% in 2025, then retreated by 25 bps to 34.33% in 2026.
• The last three FCF Margin figures came in at 34.33% (Q1 2026), 45.48% (Q4 2025), and 37.05% (Q3 2025), per Business Quant data.